HDAC5 inhibitors are a novel treatment for diabetes mellitus that increases GLUT4 gene expression [43, 44], suggesting that metrnl might also treat diabetes by increasing GLUT4 expression. This evidence concerns the gene SLC2A4 and diabetes mellitus.